Neuroblastoma risk groups refined by Children’s Oncology Group criteria
Children’s Oncology Group risk groups for neuroblastoma separate high-, low-, and intermediate-risk disease using stage, age, MYCN status, and histology.
Therapeutics, diagnostics and evidence shaping cancer care.
Therapeutics, diagnostics and evidence shaping cancer care.